Scientists produce cancer drug from rare plant in lab

September 10, 2015, Stanford University
Mayapple (Podophyllum peltatum). Credit: Wikipedia/CC BY 3.0

Many of the drugs we take today to treat pain, fight cancer or thwart disease were originally identified in plants, some of which are endangered or hard to grow. In many cases, those plants are still the primary source of the drug.

Now Elizabeth Sattely, an assistant professor of chemical engineering at Stanford, and her graduate student Warren Lau have isolated the machinery for making a widely used cancer-fighting drug from an endangered plant. They then put that machinery into a common, easily grown laboratory plant, which was able to produce the chemical. The technique could potentially be applied to other plants and drugs, creating a less expensive and more stable source for those drugs.

"People have been grinding up plants to find new chemicals and testing their activity for a really long time," Sattely said. "What was striking to us is that with a lot of the plant natural products currently used as drugs, we have to grow the plant, then isolate the compound, and that's what goes into humans."

In her work, published Sept. 10 in the journal Science, Sattely and her team used a novel technique to identify proteins that work together in a to produce the cancer drug. Her group then showed that the proteins could produce the compound outside the plant - in this case, they had put the machinery in a different plant, but they hope to eventually produce the drug in yeast. Either the plant or yeast would provide a controlled laboratory environment for producing the drug.

This work could lead to new ways of modifying the natural pathways to produce derivative drugs that are safer or more effective than the natural source.

"A big promise of synthetic biology is to be able to engineer pathways that occur in nature, but if we don't know what the proteins are, then we can't even start on that endeavor," said Sattely, who is also a member of the interdisciplinary institutes Stanford Bio-X and Stanford ChEM-H.

Finding the machinery

The drug Sattely chose to focus on is produced by a leafy Himalayan plant called the mayapple. Within the plant, a series of proteins work in a step-by-step fashion to churn out a chemical defense against predators. That chemical defense, after a few modifications in the lab, becomes a widely used cancer drug called etoposide.

The starting material for this chemical defense is a harmless molecule commonly present in the leaf. When the plant senses an attack, it begins producing proteins that make up the assembly line. One by one, those proteins add a little chemical something here, subtract something there, and after a final molecular nip and tuck, the harmless starting material is transformed into a chemical defense.

The challenge was figuring out which of the many proteins found in the mayapple leaf were the ones involved in this pathway. Sattely started with the realization that the proteins she needed to find weren't always present in the leaf. "It's only when the leaf is wounded that the molecule is made," she said.

And if the molecule is only made after wounding, the proteins that make that molecule are probably also only around after a wound as well.

The question then became, "What are all the molecules that are there after wounding?" Sattely said.

It turns out that after damaging the plant leaf, 31 new proteins appeared. Sattely and her team put various combinations of those proteins together until they eventually found 10 that made up the full assembly line. They put genes that make those 10 proteins into a common laboratory plant, and that plant began producing the chemical they were seeking.

Drugs from yeast

The eventual goal is not simply moving molecular machinery from plant to plant. Now that she's proven the molecular machinery works outside the plant, Sattely wants to put the proteins in yeast, which can be grown in large vats in the lab to better provide a stable source of drugs.

Producing a drug in yeast also provides some flexibility that isn't present when isolating a drug from plants.

"We can only use what the plant gives us," Sattely said.

In yeast, scientists can modify the genes to produce proteins with slightly different functions. For example, they could nip a little more off the chemical or add a slightly bigger side chain, or subtly alter the function of the eventual .

It may also be possible to feed the yeast a slightly different starting product, thereby changing the chemical that the molecular churns out. These approaches would provide a way of tweaking existing drugs in an effort to improve them.

Sattely said the work is a good example of how chemistry can be applied to problems of human health, which is the goal of Stanford ChEM-H. She thinks the technique she developed to find the pathway in mayapple could be applied to a wide range of other plants and drugs.

"My interests are really identifying new molecules and pathways from that are important for human health," she said.

Explore further: Team genetically engineers yeast to produce opioids

More information: "Six enzymes from Mayapple that complete the biosynthetic pathway to the etoposide aglycone," by W. Lau; E.S. Sattely, Science, … 1126/science.aac7202

Related Stories

Plants also suffer from stress

September 4, 2015

High salt in soil dramatically stresses plant biology and reduces the growth and yield of crops. Now researchers have found specific proteins that allow plants to grow better under salt stress, and may help breed future generations ...

Stressed out plants send animal-like signals

July 29, 2015

University of Adelaide research has shown for the first time that, despite not having a nervous system, plants use signals normally associated with animals when they encounter stress.

New type of drug can target all disease-causing proteins

June 11, 2015

Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.

How plant sensors detect pathogens

August 25, 2015

In the mid-20th century, an American scientist named Harold Henry Flor helped explain how certain varieties of plants can fight off some plant killers (pathogens), but not others, with a model called the "gene-for-gene" hypothesis. ...

Recommended for you

EPA adviser is promoting harmful ideas, scientists say

March 22, 2019

The Trump administration's reliance on industry-funded environmental specialists is again coming under fire, this time by researchers who say that Louis Anthony "Tony" Cox Jr., who leads a key Environmental Protection Agency ...

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Sep 10, 2015
We used to eat may apples on my grandfathers farm in southern Indiana. He told me the fruit was good but the plant is poison. It produces a yellow fruit in early spring. It was quite sweet. He cautioned about eating too many.
not rated yet Sep 11, 2015
deleted comment
not rated yet Sep 11, 2015
A Himalayan plant? But Mayapple is native to the US, and there's only one species - the one shown in the photo.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.